XCUR

Exicure (XCUR)

About Exicure (XCUR)

Exicure, Inc. develops therapeutics for immuno-oncology, genetic disorders and other indications based on its proprietary Spherical Nucleic Acid. Its product pipeline include Cavrotolimod (AST-008) and XCUR-FXN. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in June 2011 and is headquartered in Skokie, IL.

Details

Daily high

$13.91

Daily low

$12.99

Price at open

$13.30

52 Week High

$36.00

52 Week Low

$1.44

Market cap

87.9M

Dividend yield

0.00%

Volume

8,297

Avg. volume

54,241

P/E ratio

-5.37

Exicure News